Cameroon
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 8.3 (6.50 - 10.20) | 2017 | Survey/reported | Cameroon Population-based HIV Impact Assessment (CAMPHIA) 2017, 2020 |
| 4.43 (3.49 - 5.73) | 2015 | Modelled | WHO |
| 6.8 (6.50 - 7.40) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
| 12.24 (11.71 - 12.78) | 2013 | Modelled | Schweitzer et al, 2015 |
| 4.22 (3.81 - 4.55) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 4.79 (4.32 - 5.11) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.92 (4.41 - 5.28) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.96 (4.45 - 5.32) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.02 (4.45 - 5.41) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.12 (4.57 - 5.51) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.28 (4.74 - 5.68) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.45 (4.93 - 5.86) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.6 (5.11 - 6.03) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.7 (5.24 - 6.14) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.78 (5.40 - 6.13) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.9 (5.61 - 6.17) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.03 (5.82 - 6.23) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.15 (5.98 - 6.32) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.24 (6.08 - 6.40) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.36 (6.21 - 6.52) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.56 (6.40 - 6.72) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.78 (6.60 - 6.97) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.97 (6.78 - 7.18) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.07 (6.87 - 7.31) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.11 (6.91 - 7.34) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.13 (6.92 - 7.35) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.15 (6.95 - 7.37) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.17 (6.96 - 7.39) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.21 (6.98 - 7.43) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.26 (7.05 - 7.48) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.35 (7.14 - 7.58) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.46 (7.24 - 7.69) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.59 (7.35 - 7.84) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.73 (7.47 - 8.01) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.53 (4.10 - 4.88) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.9 (1.34 - 2.61) | 2015 | Modelled | WHO |
| 1.02 (0.84 - 1.22) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 1.16 (0.95 - 1.38) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.26 (1.01 - 1.46) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.35 (1.08 - 1.56) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.45 (1.15 - 1.66) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.54 (1.24 - 1.78) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.6 (1.29 - 1.85) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.66 (1.33 - 1.91) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.71 (1.36 - 1.97) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.75 (1.40 - 2.03) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.79 (1.44 - 2.09) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.82 (1.48 - 2.09) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.84 (1.53 - 2.08) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.87 (1.58 - 2.08) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.91 (1.64 - 2.11) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.98 (1.72 - 2.19) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.4 (2.13 - 2.64) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.27 (2.92 - 3.60) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.28 (3.83 - 4.73) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.14 (4.56 - 5.68) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.54 (4.88 - 6.15) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.61 (4.99 - 6.22) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.65 (5.04 - 6.26) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.67 (5.09 - 6.30) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.7 (5.12 - 6.35) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.74 (5.15 - 6.39) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.8 (5.22 - 6.42) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.87 (5.30 - 6.49) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.95 (5.34 - 6.59) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.05 (5.36 - 6.73) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.15 (5.34 - 6.92) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.75 (1.49 - 2.05) | 2020 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 1,605,000 (1,523,000 - 1,740,000) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
| 1,227,480 (1,107,980 - 1,324,080) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 1,271,830 (1,151,050 - 1,368,620) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,308,180 (1,176,500 - 1,393,340) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,307,160 (1,172,310 - 1,400,540) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,280,440 (1,149,040 - 1,370,990) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,257,820 (1,118,300 - 1,356,360) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,245,700 (1,112,080 - 1,339,430) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,244,330 (1,117,830 - 1,334,860) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,243,980 (1,126,940 - 1,335,000) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,236,590 (1,128,830 - 1,329,840) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,215,350 (1,117,180 - 1,308,300) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,191,620 (1,114,970 - 1,263,780) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,175,930 (1,119,500 - 1,229,060) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,161,900 (1,120,710 - 1,200,390) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,144,250 (1,111,550 - 1,174,730) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,118,480 (1,090,460 - 1,146,830) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,097,730 (1,072,280 - 1,124,100) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,089,920 (1,063,680 - 1,117,160) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,084,620 (1,056,190 - 1,115,100) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,073,100 (1,043,450 - 1,105,800) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,047,940 (1,017,910 - 1,082,160) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,013,360 (985,049 - 1,045,160) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 978,676 (950,490 - 1,007,810) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 944,937 (917,718 - 973,733) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 913,117 (886,518 - 940,600) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 883,931 (857,314 - 910,985) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 858,817 (833,964 - 884,772) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 838,068 (813,733 - 863,458) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 820,757 (796,612 - 846,973) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 806,150 (781,151 - 833,101) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 793,490 (766,485 - 821,581) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 7.19 (4.82 - 10.30) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 13.47 (9.37 - 19.62) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.44 (9.34 - 19.35) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.44 (9.41 - 19.20) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.38 (9.28 - 19.04) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.42 (9.39 - 19.06) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.34 (9.30 - 18.79) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.33 (9.31 - 18.79) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.4 (9.35 - 18.91) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.44 (9.34 - 19.10) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.34 (9.40 - 19.11) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.42 (9.30 - 19.49) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.35 (9.28 - 19.75) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.15 (9.09 - 19.15) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.64 (8.82 - 17.53) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.1 (8.44 - 15.97) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.71 (8.17 - 15.41) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.33 (8.03 - 14.83) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.84 (7.68 - 14.16) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.42 (7.27 - 13.76) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.12 (7.05 - 13.40) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.87 (6.76 - 13.21) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.48 (6.47 - 12.81) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.1 (5.49 - 11.36) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.99 (6.12 - 12.27) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.54 (5.83 - 11.82) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.69 (5.21 - 10.68) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.51 (5.08 - 10.65) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.41 (4.99 - 10.43) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.28 (4.88 - 10.35) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.19 (4.82 - 10.26) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 3,567 | 2016 | Modelled | WHO |
| 1,400 (973 - 2,039) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,445 (1,005 - 2,080) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,552 (1,086 - 2,217) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,495 (1,046 - 2,122) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,602 (1,111 - 2,279) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,657 (1,155 - 2,335) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,719 (1,201 - 2,423) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,794 (1,252 - 2,533) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,870 (1,299 - 2,657) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,016 (1,397 - 2,928) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,929 (1,359 - 2,763) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,136 (1,477 - 3,111) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,085 (1,449 - 3,086) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,135 (1,489 - 2,960) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,124 (1,483 - 2,804) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,138 (1,492 - 2,814) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,149 (1,523 - 2,814) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,137 (1,513 - 2,790) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,132 (1,486 - 2,814) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,146 (1,496 - 2,842) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,171 (1,485 - 2,905) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,158 (1,473 - 2,915) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,118 (1,441 - 2,891) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,079 (1,420 - 2,878) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,006 (1,358 - 2,844) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,035 (1,381 - 2,855) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,993 (1,351 - 2,769) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,038 (1,373 - 2,870) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,060 (1,382 - 2,930) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,092 (1,402 - 2,987) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,092 (1,402 - 2,987) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 67 | 2019 | Survey/reported | WHO/UNICEF |
| 69 | 2020 | Survey/reported | WHO/UNICEF |
| 69 | 2021 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.7 (0.50 - 0.80) | 2015 | Modelled | Blach et al, 2017 |
| 2.74 (2.19 - 3.46) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.74 (2.19 - 3.45) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.75 (2.20 - 3.46) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.74 (2.22 - 3.46) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.75 (2.21 - 3.46) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.77 (2.24 - 3.48) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.81 (2.27 - 3.53) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.86 (2.31 - 3.57) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.9 (2.34 - 3.64) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.93 (2.36 - 3.69) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.94 (2.37 - 3.67) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.92 (2.37 - 3.65) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.91 (2.37 - 3.62) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.9 (2.36 - 3.60) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.9 (2.36 - 3.61) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.92 (2.38 - 3.64) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.95 (2.40 - 3.68) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.97 (2.42 - 3.69) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.01 (2.44 - 3.74) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.05 (2.46 - 3.80) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.14 (2.56 - 3.86) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.32 (2.71 - 4.03) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.53 (2.92 - 4.23) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.73 (3.10 - 4.44) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.88 (3.19 - 4.60) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.97 (3.29 - 4.69) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.07 (3.37 - 4.79) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.15 (3.43 - 4.89) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.22 (3.48 - 4.99) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.26 (3.50 - 5.06) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.62 (2.10 - 3.31) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.6 (0.42 - 0.67) | 2019 | Modelled | Dugan et al., 2021 |
Prevalence of anti-HCV
Number of people living with chronic HCV (RNA+/cAg)
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 164,000 (117,000 - 184,000) | 2015 | Modelled | Blach et al, 2017 |
| 437,742 (359,650 - 519,435) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 447,845 (369,619 - 529,994) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 456,382 (377,270 - 538,978) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 463,727 (383,805 - 546,482) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 469,958 (389,320 - 554,823) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 475,346 (391,928 - 563,384) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 474,957 (394,322 - 564,965) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 466,674 (385,558 - 559,056) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 455,824 (372,604 - 553,543) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 448,348 (364,799 - 550,539) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 451,332 (364,788 - 561,795) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 462,817 (375,887 - 576,827) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 475,552 (387,695 - 590,251) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 489,589 (399,103 - 610,877) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 504,650 (410,485 - 628,659) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 520,553 (422,800 - 647,829) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 538,768 (438,077 - 670,768) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 560,052 (454,910 - 699,141) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 583,004 (471,740 - 728,930) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 605,656 (488,927 - 759,094) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 625,807 (503,368 - 789,963) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 641,189 (516,238 - 803,683) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 652,574 (526,400 - 816,818) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 662,431 (534,841 - 830,074) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 673,384 (543,507 - 847,665) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 688,620 (552,712 - 865,942) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 708,282 (570,823 - 888,980) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 729,021 (585,301 - 918,175) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 748,957 (599,131 - 943,258) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 767,995 (614,048 - 968,517) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 762,824 (609,754 - 962,146) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 37,400 (26,500 - 41,900) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
Download| Value (Deaths per 100,000) | Year | Type | Source |
|---|---|---|---|
| 0.93 (0.58 - 1.43) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 1.29 (0.91 - 1.80) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.28 (0.89 - 1.78) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.27 (0.88 - 1.77) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.27 (0.88 - 1.76) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.26 (0.87 - 1.77) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.25 (0.87 - 1.76) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.25 (0.87 - 1.77) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.26 (0.88 - 1.75) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.26 (0.86 - 1.78) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.25 (0.84 - 1.79) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.25 (0.86 - 1.76) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.23 (0.82 - 1.77) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.22 (0.81 - 1.75) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.2 (0.79 - 1.71) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.17 (0.76 - 1.69) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.13 (0.73 - 1.65) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.15 (0.75 - 1.67) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.1 (0.70 - 1.63) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.07 (0.67 - 1.58) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.05 (0.66 - 1.54) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.03 (0.64 - 1.52) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1 (0.61 - 1.51) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.99 (0.60 - 1.50) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.98 (0.59 - 1.49) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.96 (0.58 - 1.48) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.98 (0.59 - 1.50) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.96 (0.59 - 1.47) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.96 (0.59 - 1.48) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.95 (0.59 - 1.46) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.93 (0.58 - 1.43) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 1,083 | 2016 | Modelled | WHO |
| 270 (168 - 417) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 270 (168 - 417) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 268 (166 - 414) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 265 (162 - 406) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 256 (158 - 392) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 248 (151 - 385) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 246 (148 - 374) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 239 (144 - 365) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 233 (141 - 353) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 229 (139 - 344) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 226 (141 - 335) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 222 (140 - 327) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 218 (138 - 323) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 216 (137 - 321) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 214 (138 - 313) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 210 (137 - 304) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 206 (134 - 296) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 203 (134 - 289) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 199 (132 - 285) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 193 (128 - 277) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 188 (127 - 268) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 181 (124 - 255) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 176 (119 - 248) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 168 (118 - 235) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 161 (112 - 228) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 156 (108 - 219) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 151 (105 - 212) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 146 (102 - 204) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 142 (98 - 197) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 138 (96 - 191) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 134 (94 - 187) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
Hepatitis related deaths (national)
Modelled
HBV
2,092
2019
(1,402 - 2,987)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HBV chart
Modelled
HCV
270
2019
(168 - 417)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HCV chart
Prevalence < 5
HBV
1.75
(%)
2020, latest modelled
(1.49 - 2.05(%))
WHO
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines
